Novavax (NVAX) receives expanded temporary authorization for Nuvaxovid, its COVID-19 vaccine, in Switzerland for adolescents aged 12 to 17 and as a booster in adults aged 18 years and above.
The European Medicines Agency's CHMP recommends expanded conditional marketing authorization for Novavax's (NVAX) COVID-19 vaccine as a booster for adults.
Pfizer (PFE) /BioNTech (BNTX) and Moderna (MRNA) get positive CHMP opinion for Omicron-targeting bivalent booster.
It started out relatively small, or as small as a recall of one of the first drugs to top $1 billion in annual sales can be. In September 2019, individual companies began recalling popular heartburn m

Why Novavax Stock Got Pummeled Today

06:45pm, Wednesday, 31'st Aug 2022
The coronavirus' decline is continuing; meanwhile, rival vaccine developers are still moving ahead.

Why Is Novavax (NVAX) Stock Down Today?

02:54pm, Wednesday, 31'st Aug 2022
It's been a horrendous stretch for Novavax (NASDAQ: NVAX ) stock, and it's not getting any better on Wednesday. Shares of NVAX stock are down 6.5% today.
Is Novavax stock a sell after its second-quarter disappointment led to a guidance cut? NVAX stock ranks low among biotechs.
If you think investing in "meme stocks" is like playing a game of musical chairs, you might be surprised at how quickly the music might stop. The post 9 Key Meme Stocks To Run Out Of Money In Less Tha
They still might offer solid long-term opportunities for investors.

3 Growth Stocks Poised to Skyrocket

06:08am, Saturday, 27'th Aug 2022
All of them could have huge catalysts on the way.

Novavax: Finding Its Niche

02:13pm, Tuesday, 23'rd Aug 2022
The superior reactogenicity profile of Novavax's Nuvaxovid vaccine could make it the preferred choice amongst some in an endemic COVID environment. The company's other promising vaccine, NanoFlu, is b
Novavax was authorized for adults last month. Health officials now say kids as young as 12 can get Novavax.

Why Novavax Fell Today Despite Its Sunny News

05:29pm, Monday, 22'nd Aug 2022
Investors weren't impressed with the company's latest victory on the regulatory front.
Post the label expansion by the FDA, Novavax's (NVAX) COVID-19 vaccine is the first protein-based COVID vaccine authorized for use in individuals aged 12 years and older in the United States.
First Lady Jill Biden left isolation on Sunday, after testing negative for COVID twice and was able to join her husband, President Joe Biden, in Delaware.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE